Evidence map›Paper›PMID 36142262›Full record

ArticleInternational journal of molecular sciences2022

Sex-Dependent Effects of Piromelatine Treatment on Sleep-Wake Cycle and Sleep Structure of Prenatally Stressed Rats.

Jana Tchekalarova, Lidia Kortenska, Pencho Marinov, Natasha Ivanova

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jana TchekalarovaInstitute of Neurobiology, Bulgarian Academy of Sciences (BAS), 1113 Sofia, Bulgaria.ORCID 0000-0003-1640-5099
Lidia KortenskaInstitute of Neurobiology, Bulgarian Academy of Sciences (BAS), 1113 Sofia, Bulgaria.
Pencho MarinovInstitute of Information and Communication Technologies, Bulgarian Academy of Sciences (BAS), 1113 Sofia, Bulgaria.
Natasha IvanovaInstitute of Neurobiology, Bulgarian Academy of Sciences (BAS), 1113 Sofia, Bulgaria.
Bulgarian Academy of Sciences · BG

Funding

National Science Fund of Bulgaria KP-06-H21/10
6 · The paper itself

Abstract

Prenatal stress (PNS) impairs the circadian rhythm of the sleep/wake cycle. The melatonin (MT) analogue Piromelatine (Pir) was designed for the treatment of insomnia. The present study aimed to explore effects of Pir on circadian rhythmicity, motor activity, and sleep structure in male and female rats with a history of prenatal stress (PNS). In addition, we elucidated the role of MT receptors and brain-derived neurotrophic factor (BDNF) to ascertain the underlying mechanism of the drug. Pregnant rats were exposed to different stressors from day seven until birth. Piromelatine (20 mg/kg/day/14 days) was administered to young adult offspring. Home-cage locomotion, electroencephalographic (EEG) and electromyographic (EMG) recordings were conducted for 24 h. Offspring treated with vehicle showed sex-and phase-dependent disturbed circadian rhythm of motor activity and sleep/wake cycle accompanied by elevated rapid eye movement (REM) pattern and

Indexed as

Brain-Derived Neurotrophic FactorMelatoninAnimalsCircadian RhythmElectroencephalographyFemaleIndolesMalePregnancyPyransRatsReceptors, MelatoninSleepBrain-Derived Neurotrophic FactorIndolesMelatoninN-(2-(5-methoxy-indol-3-yl)-ethyl)-4-oxo-4H-pyran-2-carboxamidePyransReceptors, MelatoninBDNFmotor activitypiromelatineprenatal stresssexsleep/wake cycle

Identifiers

PMID36142262
PMCPMC9499655
OpenAlexW4294936124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.